Cargando…

Treatment outcome of patients with comorbid type 1 diabetes and eating disorders

BACKGROUND: Co-morbidity between Type 1 Diabetes Mellitus (T1DM) and eating disorders (ED) has been previously described; however the effect of this illness on the outcomes for conventional ED treatments has not been previously investigated. This study aims to compare clinical, psychopathological an...

Descripción completa

Detalles Bibliográficos
Autores principales: Custal, Nuria, Arcelus, Jon, Agüera, Zaida, Bove, Francesca I, Wales, Jackie, Granero, Roser, Jiménez-Murcia, Susana, Sánchez, Isabel, Riesco, Nadine, Alonso, Pino, Crespo, José M, Virgili, Nuria, Menchón, Jose M, Fernandez-Aranda, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030033/
https://www.ncbi.nlm.nih.gov/pubmed/24885411
http://dx.doi.org/10.1186/1471-244X-14-140
_version_ 1782317319876247552
author Custal, Nuria
Arcelus, Jon
Agüera, Zaida
Bove, Francesca I
Wales, Jackie
Granero, Roser
Jiménez-Murcia, Susana
Sánchez, Isabel
Riesco, Nadine
Alonso, Pino
Crespo, José M
Virgili, Nuria
Menchón, Jose M
Fernandez-Aranda, Fernando
author_facet Custal, Nuria
Arcelus, Jon
Agüera, Zaida
Bove, Francesca I
Wales, Jackie
Granero, Roser
Jiménez-Murcia, Susana
Sánchez, Isabel
Riesco, Nadine
Alonso, Pino
Crespo, José M
Virgili, Nuria
Menchón, Jose M
Fernandez-Aranda, Fernando
author_sort Custal, Nuria
collection PubMed
description BACKGROUND: Co-morbidity between Type 1 Diabetes Mellitus (T1DM) and eating disorders (ED) has been previously described; however the effect of this illness on the outcomes for conventional ED treatments has not been previously investigated. This study aims to compare clinical, psychopathological and personality features between two samples of ED individuals: those with comorbid T1DM and those without (No-DM); and to identify differences in treatment outcomes between the groups. METHODS: This study compares treatment outcome, dropouts, ED psychopathology and personality characteristics for 20 individuals with ED and T1DM and 20 ED patients without diabetes, matched for diagnostic and treatment type. RESULTS: The study found higher dropout rates from therapy in individuals with T1DM and worse treatment outcome in spite of having no significant differences in eating disorder psychopathology, although individuals with T1DM report misusing insulin. CONCLUSIONS: The low levels of motivation to change, and insulin abuse in T1DM patients, may suggest that treatment for patients with ED and T1DM should consider the individual’s personality and role of insulin abuse when determining the appropriate intervention.
format Online
Article
Text
id pubmed-4030033
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40300332014-05-23 Treatment outcome of patients with comorbid type 1 diabetes and eating disorders Custal, Nuria Arcelus, Jon Agüera, Zaida Bove, Francesca I Wales, Jackie Granero, Roser Jiménez-Murcia, Susana Sánchez, Isabel Riesco, Nadine Alonso, Pino Crespo, José M Virgili, Nuria Menchón, Jose M Fernandez-Aranda, Fernando BMC Psychiatry Research Article BACKGROUND: Co-morbidity between Type 1 Diabetes Mellitus (T1DM) and eating disorders (ED) has been previously described; however the effect of this illness on the outcomes for conventional ED treatments has not been previously investigated. This study aims to compare clinical, psychopathological and personality features between two samples of ED individuals: those with comorbid T1DM and those without (No-DM); and to identify differences in treatment outcomes between the groups. METHODS: This study compares treatment outcome, dropouts, ED psychopathology and personality characteristics for 20 individuals with ED and T1DM and 20 ED patients without diabetes, matched for diagnostic and treatment type. RESULTS: The study found higher dropout rates from therapy in individuals with T1DM and worse treatment outcome in spite of having no significant differences in eating disorder psychopathology, although individuals with T1DM report misusing insulin. CONCLUSIONS: The low levels of motivation to change, and insulin abuse in T1DM patients, may suggest that treatment for patients with ED and T1DM should consider the individual’s personality and role of insulin abuse when determining the appropriate intervention. BioMed Central 2014-05-16 /pmc/articles/PMC4030033/ /pubmed/24885411 http://dx.doi.org/10.1186/1471-244X-14-140 Text en Copyright © 2014 Custal et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Custal, Nuria
Arcelus, Jon
Agüera, Zaida
Bove, Francesca I
Wales, Jackie
Granero, Roser
Jiménez-Murcia, Susana
Sánchez, Isabel
Riesco, Nadine
Alonso, Pino
Crespo, José M
Virgili, Nuria
Menchón, Jose M
Fernandez-Aranda, Fernando
Treatment outcome of patients with comorbid type 1 diabetes and eating disorders
title Treatment outcome of patients with comorbid type 1 diabetes and eating disorders
title_full Treatment outcome of patients with comorbid type 1 diabetes and eating disorders
title_fullStr Treatment outcome of patients with comorbid type 1 diabetes and eating disorders
title_full_unstemmed Treatment outcome of patients with comorbid type 1 diabetes and eating disorders
title_short Treatment outcome of patients with comorbid type 1 diabetes and eating disorders
title_sort treatment outcome of patients with comorbid type 1 diabetes and eating disorders
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030033/
https://www.ncbi.nlm.nih.gov/pubmed/24885411
http://dx.doi.org/10.1186/1471-244X-14-140
work_keys_str_mv AT custalnuria treatmentoutcomeofpatientswithcomorbidtype1diabetesandeatingdisorders
AT arcelusjon treatmentoutcomeofpatientswithcomorbidtype1diabetesandeatingdisorders
AT aguerazaida treatmentoutcomeofpatientswithcomorbidtype1diabetesandeatingdisorders
AT bovefrancescai treatmentoutcomeofpatientswithcomorbidtype1diabetesandeatingdisorders
AT walesjackie treatmentoutcomeofpatientswithcomorbidtype1diabetesandeatingdisorders
AT graneroroser treatmentoutcomeofpatientswithcomorbidtype1diabetesandeatingdisorders
AT jimenezmurciasusana treatmentoutcomeofpatientswithcomorbidtype1diabetesandeatingdisorders
AT sanchezisabel treatmentoutcomeofpatientswithcomorbidtype1diabetesandeatingdisorders
AT riesconadine treatmentoutcomeofpatientswithcomorbidtype1diabetesandeatingdisorders
AT alonsopino treatmentoutcomeofpatientswithcomorbidtype1diabetesandeatingdisorders
AT crespojosem treatmentoutcomeofpatientswithcomorbidtype1diabetesandeatingdisorders
AT virgilinuria treatmentoutcomeofpatientswithcomorbidtype1diabetesandeatingdisorders
AT menchonjosem treatmentoutcomeofpatientswithcomorbidtype1diabetesandeatingdisorders
AT fernandezarandafernando treatmentoutcomeofpatientswithcomorbidtype1diabetesandeatingdisorders